177 related articles for article (PubMed ID: 27015285)
1. Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma.
Ratner L; Rauch D; Abel H; Caruso B; Noy A; Barta SK; Parekh S; Ramos JC; Ambinder R; Phillips A; Harding J; Baydoun HH; Cheng X; Jacobson S
Blood Cancer J; 2016 Mar; 6(3):e408. PubMed ID: 27015285
[No Abstract] [Full Text] [Related]
2. Adult T-cell leukemia in India: report of two cases and review of literature.
Karthik U; Ganesan P; Sagar TG; Cyriac S; Majhi U
J Cancer Res Ther; 2011; 7(3):338-40. PubMed ID: 22044818
[No Abstract] [Full Text] [Related]
3. Efficacy and Safety of the Modified EPOCH Regimen (Etoposide, Vincristine, Doxorubicin, Carboplatin, and Prednisolone) for Adult T-cell Leukemia/Lymphoma: A Multicenter Retrospective Study.
Tsukamoto Y; Kiyasu J; Choi I; Kozuru M; Uike N; Utsunomiya H; Hirata A; Fujioka E; Ohno H; Nakashima E; Nakashima Y; Miyashita K; Tachikawa Y; Narazaki T; Tsuda M; Haji S; Takamatsu A; Tanaka E; Goto T; Takatsuki H; Oyama M; Muta H; Yagi Y; Ikeda M; Matsushima T; Yufu Y; Suehiro Y
Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):e445-e453. PubMed ID: 32312633
[TBL] [Abstract][Full Text] [Related]
4. Adult T-cell leukemia-lymphoma.
Tsukasaki K
Hematology; 2012 Apr; 17 Suppl 1():S32-5. PubMed ID: 22507774
[TBL] [Abstract][Full Text] [Related]
5. Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia/lymphoma.
Jo T; Matsuzaka K; Shioya H; Tominaga H; Sakai T; Kaneko Y; Hayashi S; Matsuo M; Taguchi J; Abe K; Shigematsu K; Kubota-Koketsu R
Anticancer Res; 2020 Sep; 40(9):5237-5243. PubMed ID: 32878812
[TBL] [Abstract][Full Text] [Related]
6. Skin lesions and cytological features in HTLV-1 associated adult T-cell leukaemia/lymphoma.
Marquet J; Piris-Villaespesa M; Rodriguez E; López S; Villarrubia J; García-Vela JA
Br J Haematol; 2017 May; 177(4):507. PubMed ID: 28295186
[No Abstract] [Full Text] [Related]
7. Case Report: An Uncommon Clinical Case of Fatal Adult T-Cell Leukemia/Lymphoma Associated with HTLV-1 and Suspected due to Cutaneous Lesions and Epidemiologic Data.
Carvalho de Assis I; Rodrigues Alberti JG; Criado PR
Am J Trop Med Hyg; 2020 Nov; 103(5):2113-2115. PubMed ID: 32783798
[TBL] [Abstract][Full Text] [Related]
8. A multicenter trial of infusional etoposide, doxorubicin, and vincristine with cyclophosphamide and prednisone (EPOCH) in patients with relapsed non-Hodgkin's lymphoma.
Wilder DD; Ogden JL; Jain VK
Clin Lymphoma; 2001 Mar; 1(4):285-92. PubMed ID: 11707843
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous plaque in adult T cell leukemia/lymphoma: A case report.
Lei CS; Jiang Q; Yu Q; Qiu L
Medicine (Baltimore); 2020 Dec; 99(50):e23491. PubMed ID: 33327284
[TBL] [Abstract][Full Text] [Related]
10. An Unusual Presentation of HTLV-Associated Adult T-Cell Lymphoma/Leukemia - An Eye That Said It "A (T) LL".
Mendonca Bryne S; Hanaganahalli Basavaiah S; Christina Pinto A; Bhat G; Upadyaya K; Thahir M
Cancer Invest; 2020 Apr; 38(4):209-213. PubMed ID: 32037902
[No Abstract] [Full Text] [Related]
11. A surprising advance in the treatment of viral leukemia.
Gallo RC
N Engl J Med; 1995 Jun; 332(26):1783-5. PubMed ID: 7760898
[No Abstract] [Full Text] [Related]
12. Comorbidity between HTLV-1-associated adult T-cell lymphoma/leukemia and verrucous carcinoma: a case report.
Valencia M; Moreno L
Colomb Med (Cali); 2017 Mar; 48(1):35-38. PubMed ID: 28559645
[TBL] [Abstract][Full Text] [Related]
13. Adult T-Cell Leukemia/Lymphoma: Rarely Encountered in the United States.
Roe C; Komrokji R; Zhang L; Price S; Sokol L
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S191-4. PubMed ID: 27521318
[TBL] [Abstract][Full Text] [Related]
14. Bowenoid papulosis unveiling a rare cause of immunosuppression.
Ambooken B; Asokan N; Philip P; Jisha KT
Int J STD AIDS; 2019 Apr; 30(5):522-525. PubMed ID: 30999833
[TBL] [Abstract][Full Text] [Related]
15. Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.
Castillo JJ; Reagan JL; Sikov WM; Winer ES
Br J Haematol; 2015 May; 169(3):352-5. PubMed ID: 25612847
[TBL] [Abstract][Full Text] [Related]
16. Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma.
Farina K; Kalac M; Kim S
J Oncol Pharm Pract; 2021 Jun; 27(4):1011-1015. PubMed ID: 32869692
[TBL] [Abstract][Full Text] [Related]
17. Complete remission and proviral load negativization after allogeneic-SCT in a patient with Adult T-cell lymphoma: Case report.
Warley F; Cristaldo N; Barcan L; Valledor A; García-Rivello H; Arbelbide J; Basquiera AL; Otero V
Transpl Infect Dis; 2020 Dec; 22(6):e13350. PubMed ID: 32500925
[TBL] [Abstract][Full Text] [Related]
18. Dose-adjusted EPOCH-R for Burkitt lymphoma.
Hoelzer D
Clin Adv Hematol Oncol; 2014 Nov; 12(11):777-9. PubMed ID: 25674718
[No Abstract] [Full Text] [Related]
19. Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Ogura M; Ishida T; Tsukasaki K; Takahashi T; Utsunomiya A
Cancer Chemother Pharmacol; 2016 Jul; 78(1):199-207. PubMed ID: 27289375
[TBL] [Abstract][Full Text] [Related]
20. Adult T-Cell Leukemia/Lymphoma.
Mehta-Shah N; Ratner L; Horwitz SM
J Oncol Pract; 2017 Aug; 13(8):487-492. PubMed ID: 28796966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
